DNA Replication and Cancer Group, Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
Genome Integrity, Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
Cells. 2021 Apr 30;10(5):1068. doi: 10.3390/cells10051068.
Lysosomes, acidic, membrane-bound organelles, are not only the core of the cellular recycling machinery, but they also serve as signaling hubs regulating various metabolic pathways. Lysosomes maintain energy homeostasis and provide pivotal substrates for anabolic processes, such as DNA replication. Every time the cell divides, its genome needs to be correctly duplicated; therefore, DNA replication requires rigorous regulation. Challenges that negatively affect DNA synthesis, such as nucleotide imbalance, result in replication stress with severe consequences for genome integrity. The lysosomal complex mTORC1 is directly involved in the synthesis of purines and pyrimidines to support DNA replication. Numerous drugs have been shown to target lysosomal function, opening an attractive avenue for new treatment strategies against various pathologies, including cancer. In this review, we focus on the interplay between lysosomal function and DNA replication through nucleic acid degradation and nucleotide biosynthesis and how these could be exploited for therapeutic purposes.
溶酶体是酸性的、膜结合的细胞器,不仅是细胞回收机制的核心,还作为调节各种代谢途径的信号枢纽。溶酶体维持能量平衡,并为合成代谢过程(如 DNA 复制)提供关键底物。每次细胞分裂时,其基因组都需要正确复制;因此,DNA 复制需要严格的调控。核苷酸失衡等对 DNA 合成产生负面影响的挑战会导致复制压力,对基因组完整性造成严重后果。溶酶体复合物 mTORC1 直接参与嘌呤和嘧啶的合成,以支持 DNA 复制。大量药物已被证明可靶向溶酶体功能,为针对各种疾病(包括癌症)的新治疗策略开辟了一条有吸引力的途径。在这篇综述中,我们重点讨论了通过核酸降解和核苷酸生物合成,溶酶体功能与 DNA 复制之间的相互作用,以及如何将这些作用用于治疗目的。